BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 24071714)

  • 1. Molecular diagnosis and immunotherapy.
    Sastre J
    Curr Opin Allergy Clin Immunol; 2013 Dec; 13(6):646-50. PubMed ID: 24071714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular diagnosis and immunotherapy.
    Sastre J; Sastre-Ibañez M
    Curr Opin Allergy Clin Immunol; 2016 Dec; 16(6):565-570. PubMed ID: 27685663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How molecular diagnosis can change allergen-specific immunotherapy prescription in a complex pollen area.
    Sastre J; Landivar ME; Ruiz-García M; Andregnette-Rosigno MV; Mahillo I
    Allergy; 2012 May; 67(5):709-11. PubMed ID: 22379958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergy Work-Up Including Component-Resolved Diagnosis: How to Make Allergen-Specific Immunotherapy More Specific.
    Kleine-Tebbe J; Matricardi PM; Hamilton RG
    Immunol Allergy Clin North Am; 2016 Feb; 36(1):191-203. PubMed ID: 26617235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE; Monasterolo G
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
    Rossi RE; Monasterolo G; Coco G; Operti D
    Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific immunotherapy and biological treatments for occupational allergy.
    Moscato G; Pala G; Sastre J
    Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):576-81. PubMed ID: 25115685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular allergy diagnosis for the clinical characterization of asthma.
    Sastre-Ibañez M; Sastre J
    Expert Rev Mol Diagn; 2015 Jun; 15(6):789-99. PubMed ID: 25866231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
    Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W
    Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering of major house dust mite allergens Der p 1 and Der p 2 for allergen-specific immunotherapy.
    Asturias JA; Ibarrola I; Arilla MC; Vidal C; Ferrer A; Gamboa PM; Viñuela JE; Sanz ML; Andreu C; Martínez A
    Clin Exp Allergy; 2009 Jul; 39(7):1088-98. PubMed ID: 19400901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic reliability considerations of specific IgE determination.
    Sanz ML; Prieto I; García BE; Oehling A
    J Investig Allergol Clin Immunol; 1996; 6(3):152-61. PubMed ID: 8807505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of Hymenoptera venom allergy.
    Biló BM; Rueff F; Mosbech H; Bonifazi F; Oude-Elberink JN;
    Allergy; 2005 Nov; 60(11):1339-49. PubMed ID: 16197464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degree of olive pollen exposure and sensitization patterns. Clinical implications.
    Barber D; Moreno C; Ledesma A; Serrano P; Galán A; Villalba M; Guerra F; Lombardero M; Rodríguez R
    J Investig Allergol Clin Immunol; 2007; 17 Suppl 1():11-6. PubMed ID: 18050566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissection of the grass allergen-specific immune response in patients with allergies and control subjects: T-cell proliferation in patients does not correlate with specific serum IgE and skin reactivity.
    Würtzen PA; van Neerven RJ; Arnved J; Ipsen H; Sparholt SH
    J Allergy Clin Immunol; 1998 Feb; 101(2 Pt 1):241-9. PubMed ID: 9500758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic allergen modification in the development of novel approaches to specific immunotherapy.
    Mutschlechner S; Deifl S; Bohle B
    Clin Exp Allergy; 2009 Nov; 39(11):1635-42. PubMed ID: 19624521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific IgE response before and after rush immunotherapy with a standardized allergen or allergoid in grass pollen allergy.
    Bousquet J; Braquemond P; Feinberg J; Guerin B; Maasch H; Michel FB
    Ann Allergy; 1986 Jun; 56(6):456-9. PubMed ID: 3717711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural rubber latex and hymenoptera venoms share ImmunoglobinE-epitopes accounting for cross-reactive carbohydrate determinants.
    Mahler V; Gutgesell C; Valenta R; Fuchs T
    Clin Exp Allergy; 2006 Nov; 36(11):1446-56. PubMed ID: 17083355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Specific skin reactions induced by individual pollen preparations in hypersensitivity persons].
    Paranos S; Petrović S; Vojović I
    Srp Arh Celok Lek; 1998; 126(9-10):362-7. PubMed ID: 9863408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin test diagnosis of grass pollen allergy with a recombinant hybrid molecule.
    Metz-Favre C; Linhart B; Focke-Tejkl M; Purohit A; de Blay F; Valenta R; Pauli G
    J Allergy Clin Immunol; 2007 Aug; 120(2):315-21. PubMed ID: 17512042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticle based-immunotherapy against allergy.
    Gamazo C; Gastaminza G; Ferrer M; Sanz ML; Irache JM
    Immunotherapy; 2014; 6(7):885-97. PubMed ID: 25290419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.